Search Results - "Slonimskaya, E."

Somatic-stem transition of tumor cells is a key link in the metastasis by Litviakov, N.V., Ibragimova, M.K., Slonimskaya, E.M., Skurikhin, E.G., Tsyganov, M.M., Pershina, O.V., Deriusheva, I.V., Kazantseva, P.V.

Get full text

Breast tumour cell subpopulations with expression of the MYC and OCT4 proteins by Litviakov, N. V., Bychkov, V. A., Stakheeva, M. N., Ibragimova, M. K., Tsyganov, M. M., Gaptulbarova, K. A., Tashireva, L. A., Bondar, L. N., Garbukov, E. Yu, Slonimskaya, E. M.

“…The MYC and OCT4 genes are known factors associated with maintaining pluripotency and are linked with a more aggressive course, progression, and resistance to…”
Get full text

Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Contributes to Tamoxifen Resistance in Estrogen-Positive Breast Cancer Patients by Dronova, T. A., Babyshkina, N. N., Zavyalova, M. V., Slonimskaya, E. M., Cherdyntseva, N. V.

“…Crosstalk between the estrogen receptors and the receptor tyrosine kinases, including vascular endothelial growth factor receptor type II (VEGFR2), is a key…”
Get full text

Genome-wide association study of loss of heterozygosity and metastasis-free survival in breast cancer patients by Deryusheva, I V, Tsyganov, M, Garbukov, E Y, Ibragimova, M K, Kzhyshkovska, Ju G, Slonimskaya, E, Cherdyntseva, N V, Litviakov, N V

“…One of the factors providing the diversity and heterogeneity of malignant tumors, particularly breast cancer, are genetic variations, due to gene polymorphism,…”
Get more information

Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Contributes to Tamoxifen Resistance in Estrogen-Positive Breast Cancer Patients by Dronova, T A, Babyshkina, N N, Zavyalova, M V, Slonimskaya, E M, Cherdyntseva, N V

“…Crosstalk between the estrogen receptors and the receptor tyrosine kinases, including vascular endothelial growth factor receptor type II (VEGFR2), is a key…”
Get more information

VHL Expression in Kidney Cancer: Relation to Metastasis Development, Transcription and Growth Factors and Component of Akt/m-TOR Signaling Pathway by Spirina, L. V., Kondakova, I. V., Yurmazov, Z. A., Usynin, E. A., Slonimskaya, E. M., Lushnikova, N. A., Podnebesnova, D. V.

“…Von Hippel—Lindau protein (VHL) is associated with the development and progression of kidney cancer. An increase in VHL expression was found in patients with…”
Get full text

Transcription factors NF-kB, HIF-1, HIF-2, growth factor VEGF, VEGFR2 and carboanhydrase IX mRNA and protein level in the development of kidney cancer metastasis by Spirina, L. V., Usynin, Y. A., Yurmazov, Z. A., Slonimskaya, E. M., Kolegova, E. S., Kondakova, I. V.

“…Here, we have investigated the participation of nuclear factors NF-kB, HIF-1 and HIF-2, VEGF, VEGFR2, and carboanhydrase IX in clear-cell renal cancer. We have…”
Get full text

Clinicopathological features of nonspecific invasive breast cancer according to its molecular subtypes

“…The aim of the present study was to investigate the clinical and morphological features of nonspecific invasive breast cancer according to its molecular…”
Get more information

P6 by Babyshkina, N, Vtorushin, S, Patalyak, S, Dronova, T, Slonimskaya, E, N.Cherdyntseva

“…Background Tamoxifen, a selective estrogen receptor modulator, remains a standard of endocrine therapy for estrogen receptor alpha (ER α ) positive breast…”
Get full text

P13 by Shashova, E, Kolegova, E, Lyupina, Yu, Slonimskaya, E, Kondakova, I, Sharova, N

“…Background The tumor microenvironment plays an important role in the progression of cancer and may be regulated by proteolysis, including the proteasomes. The…”
Get full text

P77 by Litviakov, N, Ibragimova, M, Tsyganov, M, Kazantseva, P, Slonimskaya, E, Cherdyntseva, N

“…Background There are numerous evidences suggesting that tumor evolution follows the laws of Darwinian evolution, whereby individual tumor cell clones have…”
Get full text

Transcription factors NF-kB, HIF-1, HIF-2, growth factor VEGF, VEGFR2 and carboanhydrase IX mRNA and protein level in the development of kidney cancer metastasis by Spirina, L V, Usynin, Y A, Yurmazov, Z A, Slonimskaya, E M, Kolegova, E S, Kondakova, I V

“…Here, we have investigated the participation of nuclear factors NF-kB, HIF-1 and HIF-2, VEGF, VEGFR2, and carboanhydrase IX in clear-cell renal cancer. We have…”
Get more information

TRIM16 transcription factor in prostate cancer by Spirina, L. V., Gorbunov, A. К., Kondakova, I. V., Slonimskaya, E. М., Usynin, Е. A., Tarasenko, N. V.

“…The aim of this investigation was to reveal the expression TRIM16, ERα, ERβ and AR in prostate cancer tissues compared to benign hyperplasia and clinical and…”
Get full text

Changes in the Activity of Proteasomes and Calpains in Metastases of Human Lung Cancer and Breast Cancer by Shashova, E. E., Kolegova, E. S., Zav’yalov, A. A., Slonimskaya, E. M., Kondakova, I. V.

“…In patients with breast cancer and lung cancer, chymotrypsin-like and caspase-like activities of proteasomes and total activity of calpains in the primary…”
Get full text

Effect of Target Therapy on the Content of Transcription and Growth Factors, Protein Kinase TOR, and Activity of Intracellular Proteases in Patients with Metastatic Renal Cell Carcinoma by Spirina, L. V., Usynin, E. A., Kondakova, I. V., Yurmazov, Z. A., Slonimskaya, E. M.

“…We analyzed the dynamics of the expression of transcription factors, VEGF and its receptor VEGFR2, serine-threonine protein kinase mTOR and activity of…”
Get full text

P78 by Denisov, E, Gerashchenko, T, Pautova, D, Krakhmal, N, Zavyalova, M, Litviakov, N, Slonimskaya, E, Cherdyntseva, N, Perelmuter, V

“…Background Breast cancer, particularly invasive carcinoma of no special type (IC NST), demonstrates considerable intratumor morphological heterogeneity. Five…”
Get full text

A14 by Tashireva, L, Denisov, E, Savelieva, O, Zavyalova, M, Kaigorodova, E, Slonimskaya, E, Perelmuter, V

“…Background Intratumoral heterogeneity contributes significantly to the effectiveness of cancer treatment and outcome (Ng C.K., Pemberton H.N., Reis-Filho J.S.,…”
Get full text

1449 POSTER Molecular Breast Cancer Subtypes: Relationship With Angiogenesis Genes Polymorphism, Efficacy of Neoadjuvant Chemotherapy and Survival by Babvshkina, N, Zavyalova, M, Cherdyntseva, N, Slonimskaya, E, Shevchenko, A, Maximov, V

Get full text

Chymotrypsin-like activity and subunit composition of proteasomes in human cancers by Kondakova, I. V., Spirina, L. V., Koval, V. D., Shashova, E. E., Choinzonov, E. L., Ivanova, E. V., Kolomiets, L. A., Chernyshova, A. L., Slonimskaya, E. M., Usynin, E. A., Afanas’ev, S. G.

“…The activity of the proteasome, a polyfunctional enzymatic complex, is known to undergo changes during cancer development. This phenomenon is probably caused…”
Get full text

Aberrations of the number of copies (CNA) in the genome of luminal B breast tumor by Ibragimova, M. K., Tsyganov, M. M., Slonimskaya, E. M., Litviakov, N. V.

“…Aim. To describe the CNA (Copy Number Aberration) landscape of luminal B breast tumor before treatment.Materials and methods. The study included 100 patients…”
Get full text